Literature DB >> 26770569

Classification and surgical treatment for 180 cases of adrenocortical hyperplastic disease.

Yushi Zhang1, Hanzhong Li1.   

Abstract

OBJECTIVE: To review and discuss the diagnostic and surgical therapeutic methods of adrenocortical hyperplastic disease.
METHODS: A retrospective analysis was done to 180 adrenocortical hyperplasia patients (74 males, 109 females, aged 6~76 (average 40.1). Studies were done to the relationship between patients' clinical characteristics, biochemical, endocrinological and imaging examination results, the therapeutic effects.
RESULTS: Among all 180 cases, there are 107 Cushing disease (CD), 19 ectopic adrenocorticotropin adrenal hyperplasia (EAAH), 28 adrenocorticotropin independent macronodular adrenal hyperplasia (AIMAH), 4 primary pigmented nodular adrenocortical hyperplasia (PPNAH), and 28 Idiopathic Hyperaldosteronism (IHA). Twenty-four-hour urinary free cortisol (24 h UFC) excretion of CD, EAAH, AIMAH and PPNAH patients were 95.2~535.7 µg (average 287.6 µg), 24.8~808.2 µg (average 307.9 µg), 102.5~3127.0 µg (average 852.5 µg), and 243.8~1124.6 µg (average 564.3 µg). Both low and high-dose dexamethasone suppression tests (DDST) were not suppressed in AIMAH, PPNAH and EAAH groups, but HDDST was suppressed in CD group. CT thin scanning results of 180 patients all showed enlargements in the affected side adrenal gland. Unilateral adrenalectomies were performed in 102 hypercortisolism cases. Local lesion excisions were done to 21 IHA patients. 57 patients had surgeries in both sides of the adrenal glands (39 bilateral total adrenalectomies, 16 total adrenalectomy in one side andsubtotal adrenalectomy in the other, 2 bilateral subtotal adrenalectomies). 106 (59%) patients were followed up for 4~158 (average 32) months.
CONCLUSION: Unilateral adrenalectomy was the first choice for operable adrenocortical hyperplasia patients. The operation mode for the other adrenal gland should be based on the type of hyperplasia and clinical observation.

Entities:  

Keywords:  Adrenocortical hyperplasia; adrenalectomy; cushing disease; diagnosis; hyperaldosteronism; surgical treatment

Year:  2015        PMID: 26770569      PMCID: PMC4694469     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  22 in total

1.  Adrenocortical hyperplasia associated with ACTH-dependent Cushing's syndrome: comparison of the size of adrenal glands with clinical and endocrinological data.

Authors:  Toshihiro Imaki; Mitsuhide Naruse; Kazue Takano
Journal:  Endocr J       Date:  2004-02       Impact factor: 2.349

2.  Adrenal cortex disorders: hormones out of kilter.

Authors:  Ann Crawford; Helene Harris
Journal:  Nursing       Date:  2012-10

3.  A novel PRKAR1A gene mutation associated with primary pigmented nodular adrenocortical disease.

Authors:  Hui Ran; Xiaokun Ma; Qingzhu Wang; Ziyi Xie; Guijun Qin
Journal:  Am J Med Sci       Date:  2014-08       Impact factor: 2.378

Review 4.  Primary hyperaldosteronism: expanding the diagnostic net.

Authors:  Sylvia Djajadiningrat-Laanen; Sara Galac; Hans Kooistra
Journal:  J Feline Med Surg       Date:  2011-09       Impact factor: 2.015

Review 5.  Update on subclinical Cushing's syndrome.

Authors:  Lynnette K Nieman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-06       Impact factor: 3.243

Review 6.  Primary pigmented nodular adrenocortical disease and Cushing's syndrome.

Authors:  Anelia Horvath; Constantine Stratakis
Journal:  Arq Bras Endocrinol Metabol       Date:  2007-11

7.  Unilateral adrenal hyperplasia: a novel cause of surgically correctable primary hyperaldosteronism.

Authors:  Maurizio Iacobone; Marilisa Citton; Giovanni Viel; Riccardo Boetto; Italo Bonadio; Saveria Tropea; Franco Mantero; Gian Paolo Rossi; Ambrogio Fassina; Donato Nitti; Gennaro Favia
Journal:  Surgery       Date:  2012-12       Impact factor: 3.982

Review 8.  [Cushing's syndrome: special issues].

Authors:  María José Goñi Iriarte
Journal:  Endocrinol Nutr       Date:  2009-07-01

9.  Results of the prolonged use of subcutaneous continuous infusion of hydrocortisone in a man with congenital adrenal hyperplasia.

Authors:  Emmanuel Sonnet; Nathalie Roudaut; Véronique Kerlan
Journal:  ISRN Endocrinol       Date:  2011-04-12

10.  Successful treatment for adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with laparoscopic adrenalectomy: a case series.

Authors:  Toshiki Ito; Yutaka Kurita; Hitoshi Shinbo; Atsushi Otsuka; Hiroshi Furuse; Soichi Mugiya; Tomomi Ushiyama; Seiichiro Ozono; Yutaka Oki; Kazuo Suzuki
Journal:  J Med Case Rep       Date:  2012-09-18
View more
  4 in total

1.  Analysis of clinical and pathological features of primary bilateral macronodular adrenocortical hyperplasia compared with unilateral cortisol-secreting adrenal adenoma.

Authors:  Qian Zhang; Haiying Xiao; Ling Zhao; Yijun Li; Kang Chen; Li Zang; Jin Du; Xianling Wang; Qinghua Guo; Guoqing Yang; Jianming Ba; Weijun Gu; Zhaohui Lyu; Jingtao Dou; Yiming Mu; Juming Lu
Journal:  Ann Transl Med       Date:  2020-09

2.  A New Insight into the Surgical Treatment of Primary Macronodular Adrenal Hyperplasia.

Authors:  Fabio Yoshiaki Tanno; Victor Srougi; Madson Q Almeida; Fernando Ide Yamauchi; Fernando Morbeck Almeida Coelho; Mirian Yumie Nishi; Maria Claudia Nogueira Zerbini; Iracy Silvia Correa Soares; Maria Adelaide Albergaria Pereira; Helaine Laiz Silva Charchar; Amanda Meneses Ferreira Lacombe; Vania Balderrama Brondani; Miguel Srougi; Willian Carlos Nahas; Berenice B Mendonca; José Luis Chambô; Maria Candida Barisson Villares Fragoso
Journal:  J Endocr Soc       Date:  2020-07-22

3.  Demographic Characteristics, Etiology, and Comorbidities of Patients with Cushing's Syndrome: A 10-Year Retrospective Study at a Large General Hospital in China.

Authors:  Jingya Zhou; Meng Zhang; Xue Bai; Shengnan Cui; Cheng Pang; Lin Lu; Haiyu Pang; Xiaopeng Guo; Yi Wang; Bing Xing
Journal:  Int J Endocrinol       Date:  2019-02-19       Impact factor: 3.257

4.  Validity of discharge ICD-10 codes in detecting the etiologies of endogenous Cushing's syndrome.

Authors:  Jingya Zhou; Meng Zhang; Lin Lu; Xiaopeng Guo; Lu Gao; Weigang Yan; Haiyu Pang; Yi Wang; Bing Xing
Journal:  Endocr Connect       Date:  2019-08       Impact factor: 3.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.